Global Genome-Based Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Genome-Based Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Genome-Based Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Genome-Based Drug by Country/Region, 2017, 2022 & 2028

2.2 Genome-Based Drug Segment by Type

2.2.1 Insulin

2.2.2 Growth Hormone

2.2.3 Monoclonal Antibody

2.2.4 Other

2.3 Genome-Based Drug Sales by Type

2.3.1 Global Genome-Based Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Genome-Based Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Genome-Based Drug Sale Price by Type (2017-2022)

2.4 Genome-Based Drug Segment by Application

2.4.1 Hospital

2.4.2 Pharmaceutical Factory

2.4.3 Other

2.5 Genome-Based Drug Sales by Application

2.5.1 Global Genome-Based Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Genome-Based Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Genome-Based Drug Sale Price by Application (2017-2022)

3 Global Genome-Based Drug by Company

3.1 Global Genome-Based Drug Breakdown Data by Company

3.1.1 Global Genome-Based Drug Annual Sales by Company (2020-2022)

3.1.2 Global Genome-Based Drug Sales Market Share by Company (2020-2022)

3.2 Global Genome-Based Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Genome-Based Drug Revenue by Company (2020-2022)

3.2.2 Global Genome-Based Drug Revenue Market Share by Company (2020-2022)

3.3 Global Genome-Based Drug Sale Price by Company

3.4 Key Manufacturers Genome-Based Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Genome-Based Drug Product Location Distribution

3.4.2 Players Genome-Based Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Genome-Based Drug by Geographic Region

4.1 World Historic Genome-Based Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Genome-Based Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Genome-Based Drug Annual Revenue by Geographic Region

4.2 World Historic Genome-Based Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Genome-Based Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Genome-Based Drug Annual Revenue by Country/Region

4.3 Americas Genome-Based Drug Sales Growth

4.4 APAC Genome-Based Drug Sales Growth

4.5 Europe Genome-Based Drug Sales Growth

4.6 Middle East & Africa Genome-Based Drug Sales Growth

5 Americas

5.1 Americas Genome-Based Drug Sales by Country

5.1.1 Americas Genome-Based Drug Sales by Country (2017-2022)

5.1.2 Americas Genome-Based Drug Revenue by Country (2017-2022)

5.2 Americas Genome-Based Drug Sales by Type

5.3 Americas Genome-Based Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Genome-Based Drug Sales by Region

6.1.1 APAC Genome-Based Drug Sales by Region (2017-2022)

6.1.2 APAC Genome-Based Drug Revenue by Region (2017-2022)

6.2 APAC Genome-Based Drug Sales by Type

6.3 APAC Genome-Based Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Genome-Based Drug by Country

7.1.1 Europe Genome-Based Drug Sales by Country (2017-2022)

7.1.2 Europe Genome-Based Drug Revenue by Country (2017-2022)

7.2 Europe Genome-Based Drug Sales by Type

7.3 Europe Genome-Based Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Genome-Based Drug by Country

8.1.1 Middle East & Africa Genome-Based Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Genome-Based Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Genome-Based Drug Sales by Type

8.3 Middle East & Africa Genome-Based Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Genome-Based Drug

10.3 Manufacturing Process Analysis of Genome-Based Drug

10.4 Industry Chain Structure of Genome-Based Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Genome-Based Drug Distributors

11.3 Genome-Based Drug Customer

12 World Forecast Review for Genome-Based Drug by Geographic Region

12.1 Global Genome-Based Drug Market Size Forecast by Region

12.1.1 Global Genome-Based Drug Forecast by Region (2023-2028)

12.1.2 Global Genome-Based Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Genome-Based Drug Forecast by Type

12.7 Global Genome-Based Drug Forecast by Application

13 Key Players Analysis

13.1 Sandoz International

13.1.1 Sandoz International Company Information

13.1.2 Sandoz International Genome-Based Drug Product Offered

13.1.3 Sandoz International Genome-Based Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sandoz International Main Business Overview

13.1.5 Sandoz International Latest Developments

13.2 Teva pharmaceutical industries

13.2.1 Teva pharmaceutical industries Company Information

13.2.2 Teva pharmaceutical industries Genome-Based Drug Product Offered

13.2.3 Teva pharmaceutical industries Genome-Based Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Teva pharmaceutical industries Main Business Overview

13.2.5 Teva pharmaceutical industries Latest Developments

13.3 Mylan

13.3.1 Mylan Company Information

13.3.2 Mylan Genome-Based Drug Product Offered

13.3.3 Mylan Genome-Based Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Mylan Main Business Overview

13.3.5 Mylan Latest Developments

13.4 3SBio

13.4.1 3SBio Company Information

13.4.2 3SBio Genome-Based Drug Product Offered

13.4.3 3SBio Genome-Based Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 3SBio Main Business Overview

13.4.5 3SBio Latest Developments

13.5 Shanghai Fosun Pharmaceutical

13.5.1 Shanghai Fosun Pharmaceutical Company Information

13.5.2 Shanghai Fosun Pharmaceutical Genome-Based Drug Product Offered

13.5.3 Shanghai Fosun Pharmaceutical Genome-Based Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Shanghai Fosun Pharmaceutical Main Business Overview

13.5.5 Shanghai Fosun Pharmaceutical Latest Developments

13.6 Tonghua Dongbao Pharmaceutical

13.6.1 Tonghua Dongbao Pharmaceutical Company Information

13.6.2 Tonghua Dongbao Pharmaceutical Genome-Based Drug Product Offered

13.6.3 Tonghua Dongbao Pharmaceutical Genome-Based Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Tonghua Dongbao Pharmaceutical Main Business Overview

13.6.5 Tonghua Dongbao Pharmaceutical Latest Developments

13.7 Biocon

13.7.1 Biocon Company Information

13.7.2 Biocon Genome-Based Drug Product Offered

13.7.3 Biocon Genome-Based Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Biocon Main Business Overview

13.7.5 Biocon Latest Developments

13.8 Reliance Life Sciences

13.8.1 Reliance Life Sciences Company Information

13.8.2 Reliance Life Sciences Genome-Based Drug Product Offered

13.8.3 Reliance Life Sciences Genome-Based Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Reliance Life Sciences Main Business Overview

13.8.5 Reliance Life Sciences Latest Developments

13.9 Probiomed

13.9.1 Probiomed Company Information

13.9.2 Probiomed Genome-Based Drug Product Offered

13.9.3 Probiomed Genome-Based Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Probiomed Main Business Overview

13.9.5 Probiomed Latest Developments

13.10 Biosidus

13.10.1 Biosidus Company Information

13.10.2 Biosidus Genome-Based Drug Product Offered

13.10.3 Biosidus Genome-Based Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Biosidus Main Business Overview

13.10.5 Biosidus Latest Developments

13.11 AMEGA Biotech

13.11.1 AMEGA Biotech Company Information

13.11.2 AMEGA Biotech Genome-Based Drug Product Offered

13.11.3 AMEGA Biotech Genome-Based Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 AMEGA Biotech Main Business Overview

13.11.5 AMEGA Biotech Latest Developments

13.12 Celltrion

13.12.1 Celltrion Company Information

13.12.2 Celltrion Genome-Based Drug Product Offered

13.12.3 Celltrion Genome-Based Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Celltrion Main Business Overview

13.12.5 Celltrion Latest Developments

13.13 LG Life Science

13.13.1 LG Life Science Company Information

13.13.2 LG Life Science Genome-Based Drug Product Offered

13.13.3 LG Life Science Genome-Based Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 LG Life Science Main Business Overview

13.13.5 LG Life Science Latest Developments

13.14 Dong-A Pharmaceutical

13.14.1 Dong-A Pharmaceutical Company Information

13.14.2 Dong-A Pharmaceutical Genome-Based Drug Product Offered

13.14.3 Dong-A Pharmaceutical Genome-Based Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Dong-A Pharmaceutical Main Business Overview

13.14.5 Dong-A Pharmaceutical Latest Developments

14 Research Findings and Conclusion

Table 1. Genome-Based Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Genome-Based Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Insulin

Table 4. Major Players of Growth Hormone

Table 5. Major Players of Monoclonal Antibody

Table 6. Major Players of Other

Table 7. Global Genome-Based Drug Sales by Type (2017-2022) & (Kiloton)

Table 8. Global Genome-Based Drug Sales Market Share by Type (2017-2022)

Table 9. Global Genome-Based Drug Revenue by Type (2017-2022) & ($ million)

Table 10. Global Genome-Based Drug Revenue Market Share by Type (2017-2022)

Table 11. Global Genome-Based Drug Sale Price by Type (2017-2022) & (US$/Ton)

Table 12. Global Genome-Based Drug Sales by Application (2017-2022) & (Kiloton)

Table 13. Global Genome-Based Drug Sales Market Share by Application (2017-2022)

Table 14. Global Genome-Based Drug Revenue by Application (2017-2022)

Table 15. Global Genome-Based Drug Revenue Market Share by Application (2017-2022)

Table 16. Global Genome-Based Drug Sale Price by Application (2017-2022) & (US$/Ton)

Table 17. Global Genome-Based Drug Sales by Company (2020-2022) & (Kiloton)

Table 18. Global Genome-Based Drug Sales Market Share by Company (2020-2022)

Table 19. Global Genome-Based Drug Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Genome-Based Drug Revenue Market Share by Company (2020-2022)

Table 21. Global Genome-Based Drug Sale Price by Company (2020-2022) & (US$/Ton)

Table 22. Key Manufacturers Genome-Based Drug Producing Area Distribution and Sales Area

Table 23. Players Genome-Based Drug Products Offered

Table 24. Genome-Based Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Genome-Based Drug Sales by Geographic Region (2017-2022) & (Kiloton)

Table 28. Global Genome-Based Drug Sales Market Share Geographic Region (2017-2022)

Table 29. Global Genome-Based Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Genome-Based Drug Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Genome-Based Drug Sales by Country/Region (2017-2022) & (Kiloton)

Table 32. Global Genome-Based Drug Sales Market Share by Country/Region (2017-2022)

Table 33. Global Genome-Based Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Genome-Based Drug Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Genome-Based Drug Sales by Country (2017-2022) & (Kiloton)

Table 36. Americas Genome-Based Drug Sales Market Share by Country (2017-2022)

Table 37. Americas Genome-Based Drug Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Genome-Based Drug Revenue Market Share by Country (2017-2022)

Table 39. Americas Genome-Based Drug Sales by Type (2017-2022) & (Kiloton)

Table 40. Americas Genome-Based Drug Sales Market Share by Type (2017-2022)

Table 41. Americas Genome-Based Drug Sales by Application (2017-2022) & (Kiloton)

Table 42. Americas Genome-Based Drug Sales Market Share by Application (2017-2022)

Table 43. APAC Genome-Based Drug Sales by Region (2017-2022) & (Kiloton)

Table 44. APAC Genome-Based Drug Sales Market Share by Region (2017-2022)

Table 45. APAC Genome-Based Drug Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Genome-Based Drug Revenue Market Share by Region (2017-2022)

Table 47. APAC Genome-Based Drug Sales by Type (2017-2022) & (Kiloton)

Table 48. APAC Genome-Based Drug Sales Market Share by Type (2017-2022)

Table 49. APAC Genome-Based Drug Sales by Application (2017-2022) & (Kiloton)

Table 50. APAC Genome-Based Drug Sales Market Share by Application (2017-2022)

Table 51. Europe Genome-Based Drug Sales by Country (2017-2022) & (Kiloton)

Table 52. Europe Genome-Based Drug Sales Market Share by Country (2017-2022)

Table 53. Europe Genome-Based Drug Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Genome-Based Drug Revenue Market Share by Country (2017-2022)

Table 55. Europe Genome-Based Drug Sales by Type (2017-2022) & (Kiloton)

Table 56. Europe Genome-Based Drug Sales Market Share by Type (2017-2022)

Table 57. Europe Genome-Based Drug Sales by Application (2017-2022) & (Kiloton)

Table 58. Europe Genome-Based Drug Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Genome-Based Drug Sales by Country (2017-2022) & (Kiloton)

Table 60. Middle East & Africa Genome-Based Drug Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Genome-Based Drug Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Genome-Based Drug Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Genome-Based Drug Sales by Type (2017-2022) & (Kiloton)

Table 64. Middle East & Africa Genome-Based Drug Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Genome-Based Drug Sales by Application (2017-2022) & (Kiloton)

Table 66. Middle East & Africa Genome-Based Drug Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Genome-Based Drug

Table 68. Key Market Challenges & Risks of Genome-Based Drug

Table 69. Key Industry Trends of Genome-Based Drug

Table 70. Genome-Based Drug Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Genome-Based Drug Distributors List

Table 73. Genome-Based Drug Customer List

Table 74. Global Genome-Based Drug Sales Forecast by Region (2023-2028) & (Kiloton)

Table 75. Global Genome-Based Drug Sales Market Forecast by Region

Table 76. Global Genome-Based Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Genome-Based Drug Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Genome-Based Drug Sales Forecast by Country (2023-2028) & (Kiloton)

Table 79. Americas Genome-Based Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Genome-Based Drug Sales Forecast by Region (2023-2028) & (Kiloton)

Table 81. APAC Genome-Based Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Genome-Based Drug Sales Forecast by Country (2023-2028) & (Kiloton)

Table 83. Europe Genome-Based Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Genome-Based Drug Sales Forecast by Country (2023-2028) & (Kiloton)

Table 85. Middle East & Africa Genome-Based Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Genome-Based Drug Sales Forecast by Type (2023-2028) & (Kiloton)

Table 87. Global Genome-Based Drug Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Genome-Based Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Genome-Based Drug Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Genome-Based Drug Sales Forecast by Application (2023-2028) & (Kiloton)

Table 91. Global Genome-Based Drug Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Genome-Based Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Genome-Based Drug Revenue Market Share Forecast by Application (2023-2028)

Table 94. Sandoz International Basic Information, Genome-Based Drug Manufacturing Base, Sales Area and Its Competitors

Table 95. Sandoz International Genome-Based Drug Product Offered

Table 96. Sandoz International Genome-Based Drug Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 97. Sandoz International Main Business

Table 98. Sandoz International Latest Developments

Table 99. Teva pharmaceutical industries Basic Information, Genome-Based Drug Manufacturing Base, Sales Area and Its Competitors

Table 100. Teva pharmaceutical industries Genome-Based Drug Product Offered

Table 101. Teva pharmaceutical industries Genome-Based Drug Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 102. Teva pharmaceutical industries Main Business

Table 103. Teva pharmaceutical industries Latest Developments

Table 104. Mylan Basic Information, Genome-Based Drug Manufacturing Base, Sales Area and Its Competitors

Table 105. Mylan Genome-Based Drug Product Offered

Table 106. Mylan Genome-Based Drug Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 107. Mylan Main Business

Table 108. Mylan Latest Developments

Table 109. 3SBio Basic Information, Genome-Based Drug Manufacturing Base, Sales Area and Its Competitors

Table 110. 3SBio Genome-Based Drug Product Offered

Table 111. 3SBio Genome-Based Drug Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 112. 3SBio Main Business

Table 113. 3SBio Latest Developments

Table 114. Shanghai Fosun Pharmaceutical Basic Information, Genome-Based Drug Manufacturing Base, Sales Area and Its Competitors

Table 115. Shanghai Fosun Pharmaceutical Genome-Based Drug Product Offered

Table 116. Shanghai Fosun Pharmaceutical Genome-Based Drug Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 117. Shanghai Fosun Pharmaceutical Main Business

Table 118. Shanghai Fosun Pharmaceutical Latest Developments

Table 119. Tonghua Dongbao Pharmaceutical Basic Information, Genome-Based Drug Manufacturing Base, Sales Area and Its Competitors

Table 120. Tonghua Dongbao Pharmaceutical Genome-Based Drug Product Offered

Table 121. Tonghua Dongbao Pharmaceutical Genome-Based Drug Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 122. Tonghua Dongbao Pharmaceutical Main Business

Table 123. Tonghua Dongbao Pharmaceutical Latest Developments

Table 124. Biocon Basic Information, Genome-Based Drug Manufacturing Base, Sales Area and Its Competitors

Table 125. Biocon Genome-Based Drug Product Offered

Table 126. Biocon Genome-Based Drug Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 127. Biocon Main Business

Table 128. Biocon Latest Developments

Table 129. Reliance Life Sciences Basic Information, Genome-Based Drug Manufacturing Base, Sales Area and Its Competitors

Table 130. Reliance Life Sciences Genome-Based Drug Product Offered

Table 131. Reliance Life Sciences Genome-Based Drug Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 132. Reliance Life Sciences Main Business

Table 133. Reliance Life Sciences Latest Developments

Table 134. Probiomed Basic Information, Genome-Based Drug Manufacturing Base, Sales Area and Its Competitors

Table 135. Probiomed Genome-Based Drug Product Offered

Table 136. Probiomed Genome-Based Drug Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 137. Probiomed Main Business

Table 138. Probiomed Latest Developments

Table 139. Biosidus Basic Information, Genome-Based Drug Manufacturing Base, Sales Area and Its Competitors

Table 140. Biosidus Genome-Based Drug Product Offered

Table 141. Biosidus Genome-Based Drug Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 142. Biosidus Main Business

Table 143. Biosidus Latest Developments

Table 144. AMEGA Biotech Basic Information, Genome-Based Drug Manufacturing Base, Sales Area and Its Competitors

Table 145. AMEGA Biotech Genome-Based Drug Product Offered

Table 146. AMEGA Biotech Genome-Based Drug Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 147. AMEGA Biotech Main Business

Table 148. AMEGA Biotech Latest Developments

Table 149. Celltrion Basic Information, Genome-Based Drug Manufacturing Base, Sales Area and Its Competitors

Table 150. Celltrion Genome-Based Drug Product Offered

Table 151. Celltrion Genome-Based Drug Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 152. Celltrion Main Business

Table 153. Celltrion Latest Developments

Table 154. LG Life Science Basic Information, Genome-Based Drug Manufacturing Base, Sales Area and Its Competitors

Table 155. LG Life Science Genome-Based Drug Product Offered

Table 156. LG Life Science Genome-Based Drug Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 157. LG Life Science Main Business

Table 158. LG Life Science Latest Developments

Table 159. Dong-A Pharmaceutical Basic Information, Genome-Based Drug Manufacturing Base, Sales Area and Its Competitors

Table 160. Dong-A Pharmaceutical Genome-Based Drug Product Offered

Table 161. Dong-A Pharmaceutical Genome-Based Drug Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 162. Dong-A Pharmaceutical Main Business

Table 163. Dong-A Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Genome-Based Drug

Figure 2. Genome-Based Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Genome-Based Drug Sales Growth Rate 2017-2028 (Kiloton)

Figure 7. Global Genome-Based Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Genome-Based Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Insulin

Figure 10. Product Picture of Growth Hormone

Figure 11. Product Picture of Monoclonal Antibody

Figure 12. Product Picture of Other

Figure 13. Global Genome-Based Drug Sales Market Share by Type in 2021

Figure 14. Global Genome-Based Drug Revenue Market Share by Type (2017-2022)

Figure 15. Genome-Based Drug Consumed in Hospital

Figure 16. Global Genome-Based Drug Market: Hospital (2017-2022) & (Kiloton)

Figure 17. Genome-Based Drug Consumed in Pharmaceutical Factory

Figure 18. Global Genome-Based Drug Market: Pharmaceutical Factory (2017-2022) & (Kiloton)

Figure 19. Genome-Based Drug Consumed in Other

Figure 20. Global Genome-Based Drug Market: Other (2017-2022) & (Kiloton)

Figure 21. Global Genome-Based Drug Sales Market Share by Application (2017-2022)

Figure 22. Global Genome-Based Drug Revenue Market Share by Application in 2021

Figure 23. Genome-Based Drug Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Genome-Based Drug Revenue Market Share by Company in 2021

Figure 25. Global Genome-Based Drug Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Genome-Based Drug Revenue Market Share by Geographic Region in 2021

Figure 27. Global Genome-Based Drug Sales Market Share by Region (2017-2022)

Figure 28. Global Genome-Based Drug Revenue Market Share by Country/Region in 2021

Figure 29. Americas Genome-Based Drug Sales 2017-2022 (Kiloton)

Figure 30. Americas Genome-Based Drug Revenue 2017-2022 ($ Millions)

Figure 31. APAC Genome-Based Drug Sales 2017-2022 (Kiloton)

Figure 32. APAC Genome-Based Drug Revenue 2017-2022 ($ Millions)

Figure 33. Europe Genome-Based Drug Sales 2017-2022 (Kiloton)

Figure 34. Europe Genome-Based Drug Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Genome-Based Drug Sales 2017-2022 (Kiloton)

Figure 36. Middle East & Africa Genome-Based Drug Revenue 2017-2022 ($ Millions)

Figure 37. Americas Genome-Based Drug Sales Market Share by Country in 2021

Figure 38. Americas Genome-Based Drug Revenue Market Share by Country in 2021

Figure 39. United States Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Genome-Based Drug Sales Market Share by Region in 2021

Figure 44. APAC Genome-Based Drug Revenue Market Share by Regions in 2021

Figure 45. China Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Genome-Based Drug Sales Market Share by Country in 2021

Figure 52. Europe Genome-Based Drug Revenue Market Share by Country in 2021

Figure 53. Germany Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Genome-Based Drug Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Genome-Based Drug Revenue Market Share by Country in 2021

Figure 60. Egypt Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Genome-Based Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Genome-Based Drug in 2021

Figure 66. Manufacturing Process Analysis of Genome-Based Drug

Figure 67. Industry Chain Structure of Genome-Based Drug

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles